• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：BRD4抑制剂AZD5153抑制结肠癌细胞增殖并增强PARP抑制剂的抗癌效果：勘误。

Erratum: BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor: Erratum.

作者信息

Zhang Peng, Li Ruidong, Xiao Hua, Liu Weizhen, Zeng Xiangyu, Xie Genchen, Yang Wenchang, Shi Liang, Yin Yuping, Tao Kaixiong

机构信息

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Gastroduodenal and Pancreatic Surgery, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, No. 283 Tongzipo Road, Changsha, Hunan Province 410013, China.

出版信息

Int J Biol Sci. 2022 May 27;18(9):3795-3797. doi: 10.7150/ijbs.73868. eCollection 2022.

DOI:10.7150/ijbs.73868
PMID:35813485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9254472/
Abstract

[This corrects the article DOI: 10.7150/ijbs.34162.].

摘要

[本文更正文章DOI：10.7150/ijbs.34162。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/b6eb846b8ecd/ijbsv18p3795g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/ac35bf67d74e/ijbsv18p3795g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/e9ca7deaecb9/ijbsv18p3795g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/b6eb846b8ecd/ijbsv18p3795g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/ac35bf67d74e/ijbsv18p3795g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/e9ca7deaecb9/ijbsv18p3795g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5372/9254472/b6eb846b8ecd/ijbsv18p3795g003.jpg

相似文献

1
Erratum: BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor: Erratum.勘误：BRD4抑制剂AZD5153抑制结肠癌细胞增殖并增强PARP抑制剂的抗癌效果：勘误。
Int J Biol Sci. 2022 May 27;18(9):3795-3797. doi: 10.7150/ijbs.73868. eCollection 2022.
2
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.BRD4 抑制剂 AZD5153 抑制结直肠癌细胞的增殖并增强 PARP 抑制剂的抗癌作用。
Int J Biol Sci. 2019 Jul 21;15(9):1942-1954. doi: 10.7150/ijbs.34162. eCollection 2019.
3
AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells.AZD5153，一种双价BRD4抑制剂，通过改变BRD4染色体格局和调节肝癌细胞转录组来抑制肝癌发生。
Front Cell Dev Biol. 2022 Mar 24;10:853652. doi: 10.3389/fcell.2022.853652. eCollection 2022.
4
AZD5153, a novel BRD4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo.AZD5153，一种新型的 BRD4 抑制剂，在体外和体内抑制人甲状腺癌细胞生长。
Biochem Biophys Res Commun. 2018 May 15;499(3):531-537. doi: 10.1016/j.bbrc.2018.03.184. Epub 2018 Mar 31.
5
AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo.AZD5153在体外和体内均可抑制前列腺癌细胞的生长。
Cell Physiol Biochem. 2018;50(2):798-809. doi: 10.1159/000494244. Epub 2018 Oct 11.
6
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.AZD5153：一种新型双价 BET 溴结构域抑制剂，对血液系统恶性肿瘤具有高度活性。
Mol Cancer Ther. 2016 Nov;15(11):2563-2574. doi: 10.1158/1535-7163.MCT-16-0141. Epub 2016 Aug 29.
7
BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.BRD4 抑制剂 AZD5153 通过去极化 M2 巨噬细胞促进抗肿瘤免疫。
Front Immunol. 2020 Feb 28;11:89. doi: 10.3389/fimmu.2020.00089. eCollection 2020.
8
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.勘误：雷公藤甲素抑制糖尿病肾病中肾小球系膜细胞增殖与抑制PDK1/Akt/mTOR信号通路相关：勘误。
Int J Biol Sci. 2020 Oct 3;16(15):3037-3038. doi: 10.7150/ijbs.53769. eCollection 2020.
9
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.双重靶向含有溴结构域蛋白 4 的 AZD5153 和 BCL2 的 AZD4320 联合治疗同时过表达 c-MYC 和 BCL2 的 B 细胞淋巴瘤。
Invest New Drugs. 2019 Apr;37(2):210-222. doi: 10.1007/s10637-018-0623-8. Epub 2018 Jun 21.
10
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.勘误：雷公藤甲素抑制糖尿病肾病中肾小球系膜细胞增殖与抑制PDK1/Akt/mTOR信号通路相关：勘误
Int J Biol Sci. 2024 Sep 5;20(12):4781-4782. doi: 10.7150/ijbs.101944. eCollection 2024.